Comparison of the Oxoid Clostridium difficile toxin A detection kit with cytotoxin detection by a cytopathic effect method examined at 4, 6, 24 and 48 h

Clinical Microbiology and Infection

Volumn 5, Issue 11, 1999, Pages 698-701

  Settle, Christopher D ^a   Wilcox, Mark H ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Clostridium difficile; Diagnosis; Toxin testing

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CYTOTOXIN;

ARTICLE; BACTERIUM CULTURE; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DIAGNOSTIC ACCURACY; DIARRHEA; FECES ANALYSIS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THAWING; UNITED KINGDOM;

BACTERIA (MICROORGANISMS); CLOSTRIDIUM DIFFICILE;

EID: 0032749235     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1999.tb00516.x     Document Type: Article

References (19)

1. Department of Health and Public Health Laboratory Service Joint Working Group. Clostridium difficile infection. Prevention and management. Heywood: BAPS Health Publication Unit, DSS Distribution Centre, 1994.
2. Dodson AP, Borriello SP. Clostridium difficile infection of the gut. J Clin Pathol 1996; 49: 529-32.
3. Riley TV, Coddé JP, Rouse IL. Increased length of hospital stay due to Clostridium difficile associated diarrhoea. Lancet 1995; 345: 455-6.
4. Wilcox MH. Cleaning up Clostridium difficile infection. Lancet. 1996; 348: 767-8.
5. Chang T-W, Lauermann M, Bartlett JG. Cytotoxicity assay in antibiotic-associated colitis. J Infect Dis 1979; 140: 765-70.
6. Brazier JS. Cross reactivity of Clostridium glycolicum with the latex particle agglutination reagent for C. difficile identification. In Borriello SP, ed. Clinical and molecular aspects of anaerobes. Petersfield: Wrightson Biomedical Publishing, 1990: 293-6.
7. Bentley AH, Patel NB, Sidorczuk M, et al. Multicentre evaluation of a commercial test for the rapid diagnosis of Clostridium difficile-mediated antibiotic-associated diarrhoea. Eur J Clin Microbiol Infect Dis 1998; 17: 788-90.
8. Lyerly DM, Krivan HC, Wilkins TD. Clostridium difficile: its disease and toxins. Clin Microbiol Rev 1988; 1: 1-18.
9. Sullivan NM, Pellett S, Wilkins TD. Purification and characterization of toxins A and B of Clostridium difficile. Infect Immun 1982; 35: 1032-40.
10. Borriello SP, Wren BW, Hyde S, et al. Molecular, immunological, and biological characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun 1992; 60: 4192-99.
11. Lyerly DM, Sullivan NM, Wilkins TD. Enzyme-linked immunosorbent assay for Clostridium difficile toxin A. J Clin Microbiol 1983; 17: 72-8.
12. Borriello SP, Vale T, Brazier JS, Hyde S, Chippeck E. Evaluation of a commercial enzyme immunoassay kit for the detection of Clostridium difficile toxin A. Eur J Clin Microbiol Infect Dis 1992; 11: 360-3.
13. Lyerly DM, Roberts MD, Phelps CJ, Wilkins TD. Purification and properties of toxins A and B of Clostridium difficile. FEMS Microbiol Lett 1986; 33: 31-5.
14. Lyerly DM, Barroso LA, Wilkins TD, Depitre C, Corthier G. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun 1992; 60: 4633-9.
15. Kato H, Kato N, Watanabe K, et al. Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J Clin Microbiol 1998; 36: 2178-82.
16. Brazier JS. The epidemiology and typing ot Clostridium difficile. J Antimicrob Chemother 1998; 41(suppl C): S47-57.
17. Sambol S, Gerding D, Merrigan M, Lyerly D, Johnson S. Severe truncation of the toxin A gene in a pathogenic Clostridium difficile (CD) strain not detectable by toxin A immunoassay. Clin Infect Dis 1998; 27: 946.
18. Kato H, Kato N, Fukui K, Ohara A, Watanabe K. High prevalence of toxin A-negative toxin B-positive Clostridium difficile strains among adult inpatients. Clin Microbiol Infect 1997; 3(suppl 2): S220.
19. Olson MM, Shanholtzer CJ, Lee JT, Gerding DN. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991. Infect Control Hosp Epidemiol 1994; 15: 371-81.